| Views | |
|---|---|
| GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 151 |
| September 2024 | October 2024 | November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | |
|---|---|---|---|---|---|---|---|
| GD2-directed bispecific trifunctional antibody outperforms dinutuximab beta in a murine model for aggressive metastasized neuroblastoma | 4 | 3 | 5 | 1 | 1 | 14 | 4 |
| Views | |
|---|---|
| 2021_Zirngibl_etal.pdf | 197 |
